Psyllium (Extra Profile)
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
Psyllium (Extra Profile). Viscous fiber with strong LDL-lowering effect.
How it works. Binds bile acids → liver pulls cholesterol → LDL decreases.
What the research supports. 1 graded claims. Strongest: Lowers LDL by ~7% (strong).
How much to take. Typical dose: 10 g/day, divided.
Side effects and interactions. 1 medication interaction listed. Serious: Take separate from meds.
Stacking. Pairs well with A high-quality multivitamin, Omega-3 (EPA/DHA).
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried Psyllium (Extra Profile). Anecdotes are not medical advice.
Psyllium (Extra Profile). Viscous fiber with strong LDL-lowering effect.
What it is
Viscous fiber with strong LDL-lowering effect.
Food sources
Goals
How it works
Binds bile acids → liver pulls cholesterol → LDL decreases.
Pathways
- Binds bile acids → liver pulls cholesterol → LDL decreases
Effects
- ↓LDL by ~7% decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- Bloating
Serious
- Take separate from meds
Medication interactions
Always disclose Psyllium (Extra Profile) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- A high-quality multivitaminCovers micronutrient cofactors that support most supplement pathways.
- Omega-3 (EPA/DHA)Foundational anti-inflammatory support that complements most regimens.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Significant reductions in LDL-C, non-HDL-C and apo B.
Opens current human and preclinical literature matching Psyllium (Extra Profile) and "Lowers LDL by ~7%". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Psyllium (Extra Profile) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…